Success is a collaborative effort…
BioDerm’s executive team has maintained a 32.5% CAGR each year since 2011, more than doubled staff to support growth, expanded manufacturing, and updated its technology to improve efficiency and facilitate growth.
In addition, we have:
- Helped improve the lives of tens of thousands of incontinent men
- Secured 10 US and international patents protecting our innovative designs and intellectual property, with additional patents pending
- Established new partnerships with major U.S. and international distribution partners, most notably Medline industries, to expand product penetration into the acute care market
- Successfully completed ISO-13485 certification for manufacturing and exporting to major international markets
- Long term membership with the Better Business Bureau and maintained an A+ rating
- Since 2012, BioDerm’s products have been sold in over 10 countries, in over 700 domestic hospitals and to more than 40,000 direct consumers.
Gary Damkoehler, Executive Chairman of the Board
Damkoehler is a veteran healthcare industry executive and former Chairman of the Board of JSA Healthcare Corporation. After successful stints at USAID and Westinghouse’s Health Systems Division, he joined the predecessor company to JSA in 1984. Damkoehler founded JSA’s Government Services Division, which grew from $120,000 in sales in 1984 to $21.4 million in 1994, an achievement that placed the company on the Inc. 500 List. He was appointed President of JSA in 1985 and Chairman of the Board in 1988. In 1992, he led JSA into the managed care arena, growing to 65 facilities and revenues of $210 million in 2005.
Damkoehler holds a Bachelor’s degree in Economics from the University of Alabama and a Master’s degree in Economics from the University of Alabama.
Tyranski is a global P&L Executive with a proven track record of organic and inorganic growth, continuous improvement, customer satisfaction and employee development. He is a veteran of multiple rapid-growth organizations, including start-ups and multi-million-dollar healthcare manufacturers and service providers including Jabil Circuit, Inc. and Synergy Health plc. Gaet has extensive international experience having resided in China, Hong Kong, England, Scotland, Italy and Austria (commuting to Hungary) during his career. Tyranski is responsible for accelerating BioDerm’s aggressive growth plans, will oversee BioDerm’s diverse manufacturing and R&D portfolio, ensure strict FDA compliance and support BioDerm’s B2B, B2C and international marketing and sales efforts. He is also a Board Member of the Florida Medical Manufacturers Consortium (FMMC).
Gaet holds a Bachelor’s degree in Economics and Political Science from Bucknell University and a Master of Business Administration from the University of Florida, Gainesville.
Stone has more than 20 years of experience in operations, materials, supply chain and project management, with an emphasis on regulated industries including aerospace and medical device. His background has led to full knowledge of ERP system conversions, MRP, Demand Planning, Mil standards, GSI, FAR, DFARS, cGMP and GDP, ISO 13485, ISO 9001, AS 9100, OHSAS 80001, and ISO 14001. Lean trained by Boeing, Stone is a Certified Six Sigma Black Belt who is proficient in resolving and implementing Corrective and Preventative Actions (CAPAs). Shawn developed the ability to lead cross functional teams, implement ISO systems, train employees on standards, identify cost savings opportunities through Six Sigma, and manage projects to increase productivity and improve performance. Prior to joining Bioderm in 2016, Stone was Operations Manager at Synergy Health, and has held various management positions at Chromalloy Gas Turbine and Smiths Medical.
Shawn received his Bachelor of Arts in Business from Aurora University, Aurora, Illinois.
Marc Garofani came to BioDerm, Inc. as a finance manager with extensive hands-on experience in financial management and business leadership within the medical field. Garofani has worked with several respected companies including PricewaterhouseCoopers LLC, First Advantage Corporation, and Chromalloy Casting Tampa, Corp. Prior to BioDerm, Inc., Garofani worked with TouchPoint Medical, Inc. as Americas Finance Director. While at TouchPoint Medical, Inc., he was a member of the TPM senior leadership team responsible for the overall financial health of the company by providing the operational and strategic financial guidance, managing the accounting and financial control functions, and establishing the financial roadmap for the profitable long-term growth of the business. Garofani also worked with STERIS Corporation as the Global Finance Director & Director of Customer Economic Support. During his time at STERIS, Garofani was a key finance member of the global HSS/IMS business leadership team, focused on financial and business value drivers, providing pertinent financial and business advice, and actively supporting the business and its customers. Additionally, Garofani held the position of Global Finance Director with Synergy Health PLC where he was a key member of the global business leadership team, focused on financial and business value drivers, providing pertinent financial and business advice, and actively supported the business and its customers.
Garofani is a certified public accountant and holds a Bachelor of Science degree in Accounting and Business Administration from the University of South Florida. He is affiliated with the Florida Institute of Certified Public Accountants and the Healthcare Financial Management Association.
Jim Terpstra, Vice President Sales (Acute & VAD)
Jim Terpstra is a healthcare sales executive with an established track record of success in developing sales teams that achieve excellent results. Since joining BioDerm in 2013, Terpstra has been responsible for expanding sales of BioDerm’s revolutionary products for catheter securement and male urinary incontinence. He is overseeing expansion plans, including a move into new markets—integrated care networks, hospital systems and long-term care facilities—and has brought on several new distribution partners, secured GPO contracts, and developed the company’s direct and independent sales force from the ground zero.
Before joining BioDerm Inc., Jim was the Director of Corporate Accounts for Eloquest Healthcare (Ferndale, MI), where he was responsible for negotiating contracts with GPOs, distributors, and integrated delivery networks (IDN’s) for product sales and distribution. Prior to Eloquest Healthcare, Jim spent nine years with Sage Products Inc. (Cary, IL), where he held sales and leadership positions in Corporate Accounts.
The Michigan native received his Bachelor of Arts degree in Business Administration from Northwood University in Midland, MI.
Matt Geary, Director of Information Technology
Geary is an information technology leader with an emphasis on systems engineering, network administration, information security, and database management. Since joining BioDerm in 2015, Matt has architected and implemented a scalable IT infrastructure, reduced the cost of operations, reduced network downtime, enhanced call center efficiency, implemented mission-critical software programs to sustain company growth, improved customer lead generation through digital content marketing and data analysis, and spearheaded compliance efforts. Matt is the company HIPAA Security Officer, GDPR Data Protection Officer, PCI Compliance Officer, as well as responsible for TCPA & DNC compliance.
Prior to joining BioDerm, Matt founded a business performing contract work for Google, evaluating websites and optimizing search engine queries, as well as founding an online startup business providing online game services to thousands of clients worldwide. Previously, he founded a business providing all-in-one IT support for the Florida Aquarium, where he was the network administrator for several years, as well as developed and implemented mission-critical custom-built ticketing software for reservation, membership, donation, and front desk and online ticketing systems.
Matt has an AA of Liberal Arts from Hillsborough Community College and perennially continues his professional education with enrollments in MIS Training Institute and (ISC)².
Mrs. Seguinot is an experienced Quality Assurance professional with over 15 years of experience and has been highly successful in sustaining Good Manufacturing Practices (GMP). Her expertise includes recommendations for improvements, inspections, and validations; while concurrently maintaining compliance with regulatory and accrediting agencies (ISO, FDA).
Prior to joining BioDerm, she worked in FDA-regulated environments including QA Manager at Synergy Health Plc, Microbiology Senior Analyst for both Nephron Pharmaceuticals and Smith & Nephew, and Laboratory Compliance Coordinator at Cryo-Cell International.
Mrs. Seguinot holds a Bachelor of Science Degree in Industrial Microbiology from the University of Puerto Rico in Mayagüez.
Board of Directors
Gary Damkoehler, Series A Director
Gaet Tyranski, President & CEO
Brian Highley is an accomplished Executive experienced in Operations, Business Development, and Research & Development. Highley began his professional career in engineering, working with several notable companies such as Picker International, Smith and Nephew Endoscopy, Baxter Healthcare, Medtronic, FlexMedical, and Nypro Healthcare. He is currently CEO at Cirtec Medical Corporation, a company that brings Class III medical devices from active implants to minimally invasive therapeutic devices to market quickly, predictably, and cost-effectively. Over the course of his career, Highley has been granted 9 patents, all related to the medical field. Prior to Highley’s engineering career, he served in the United States Marine Corps and participated in Operation Just Cause in the Republic of Panama and Operation Desert Shield/Storm in the Persian Gulf. Highley received his Bachelor of Science in BSE Biomedical Engineering with a minor in Mathematics through Mercer University.
Dr. Charles W. Mulford, CPA
Dr. Charles W. Mulford is Invesco Chair and Professor of Accounting in the College of Management at Georgia Tech. He is a founding shareholder of Cash Flow Analytics, LLC, a firm dedicated to providing software solutions for credit and investment analysis. In addition, he consults regularly with large commercial banks and investment firms. Dr. Mulford has co-authored four books on financial analysis and the warning signs of financial fraud, including the best-selling The Financial Number Game and Creative Cash Flow Reporting. Dr. Mulford has appeared on numerous broadcast networks, including CNBC, ABC News, and Bloomberg TV, and is quoted regularly in numerous business publications, including the Wall Street Journal, Business Week, and CFO Magazine. Dr. Mulford has served on the Board of Directors for BioDerm, Inc. since 1999. Dr. Mulford received his Ph.D. in Accounting from Florida State University.